Definition and Overview
Postural orthostatic tachycardia syndrome (POTS) is a chronic autonomic nervous system disorder characterized by an excessive increase in heart rate upon standing without accompanying orthostatic hypotension. According to the 2015 Heart Rhythm Society (HRS) expert consensus statement, POTS is diagnosed in adults when heart rate increases by 30 beats per minute (bpm) or more within 10 minutes of standing, or when the absolute heart rate exceeds 120 bpm, without a systolic blood pressure drop of 20 mmHg or more [1]. For adolescents aged 12–19 years, the heart rate increase threshold is 40 bpm or more [7].
POTS is not a single disease but a syndrome involving multiple pathophysiological mechanisms [2]. In addition to the abnormal heart rate response upon standing, patients experience a wide range of symptoms including dizziness, palpitations, chronic fatigue, brain fog, and exercise intolerance.
It is estimated that approximately 1–3 million people in the United States have POTS [5]. Approximately 80% of patients are women of childbearing age, with onset typically occurring between ages 15 and 50 [2]. The female-to-male ratio is approximately 5:1 [3]. In a large cohort study from Mayo Clinic, the mean age of onset was 30 years, and the average time from symptom onset to diagnosis was 5 years and 11 months [3]. This reflects the reality of delayed diagnosis due to insufficient awareness of POTS.
The term "POTS" was first coined by Schondorf and Low in 1993. Diagnostic criteria were subsequently formalized in the 2011 international consensus statement [7], and treatment guidelines were established through the 2015 HRS consensus statement [1]. In 2019, the National Institutes of Health (NIH) convened an expert consensus meeting that redefined research priorities [5].
Causes and Subtypes
The etiology of POTS is not singular; subtypes are classified according to different pathophysiological mechanisms. It is common for multiple mechanisms to overlap in a single patient [2] [5].
Neuropathic POTS
This subtype results from damage to peripheral autonomic nerves, particularly sympathetic fibers innervating the lower extremities and splanchnic vasculature. Insufficient vasoconstriction upon standing leads to venous blood pooling in the lower body, triggering a compensatory excessive increase in heart rate [2]. Small fiber neuropathy has been reported in approximately 50% of POTS patients [3]. Skin biopsy frequently reveals reduced intraepidermal nerve fiber density.
Hyperadrenergic POTS
This subtype is characterized by excessive norepinephrine release upon standing. Upright plasma norepinephrine levels exceeding 600 pg/mL are characteristic [2]. It is observed in approximately 30–60% of all POTS patients, and systolic blood pressure may paradoxically rise upon standing. Tremor, anxiety, and excessive sweating are frequently associated.
Hypovolemic POTS
This subtype involves an absolute deficit in circulating blood volume. Studies have shown that plasma volume in POTS patients is reduced by approximately 13% compared to controls [4]. The volume deficit leads to decreased venous return to the heart upon standing, resulting in a compensatory increase in heart rate. Dysregulation of the renin-angiotensin-aldosterone system is thought to be involved.
Autoimmune POTS
This subtype is caused by autoantibodies attacking autonomic nervous system receptors. Approximately 25% of POTS patients are positive for antinuclear antibodies (ANA) [3], and autoantibodies against adrenergic receptors, muscarinic receptors, and ganglionic acetylcholine receptors have been reported [5]. There is a high frequency of comorbidity with autoimmune diseases such as Sjogren syndrome and Hashimoto thyroiditis.
Post-infectious POTS
This subtype develops within weeks to months following a viral or bacterial infection. Although POTS has previously been reported following infectious mononucleosis (Epstein-Barr virus) and Lyme disease, post-infectious POTS has surged globally since the COVID-19 pandemic. Approximately 2–14% of COVID-19 patients develop post-infectious autonomic dysfunction, and a substantial proportion meet POTS diagnostic criteria [6]. Blitshteyn and Whitelaw (2021) reported that POTS was confirmed in the majority of 20 patients with post-COVID-19 autonomic disorders [6]. Molecular mimicry, whereby post-infectious immune responses attack autonomic nerve fibers or receptors, is the leading proposed mechanism.
Symptoms
A common feature of POTS symptoms is that they worsen upon standing and improve when lying down [1] [2].
Cardiovascular Symptoms
Excessive heart rate increase upon standing is the hallmark finding. Palpitations are the most commonly reported symptom, and chest discomfort or chest pain may also occur. A transient rise in systolic blood pressure upon standing is observed in some patients [2].
Neurological Symptoms
Dizziness and headache are the most common neurological symptoms, and presyncope may occur. Actual syncope is relatively uncommon, reported in approximately 30% of POTS patients [3]. Cognitive impairment described as "brain fog" is very prevalent and includes difficulty concentrating, memory deficits, and slowed processing speed. Cognitive function in POTS patients is significantly impaired in the upright position and normalizes in the supine position.
Systemic Symptoms
Chronic fatigue is present in approximately 48–77% of POTS patients [3]. Exercise intolerance causes extreme fatigue and symptom exacerbation even with mild physical activity. Sleep disturbances are frequently comorbid, creating a vicious cycle in which poor sleep quality further worsens fatigue.
Gastrointestinal Symptoms
Nausea, abdominal pain, bloating, and early satiety are common. Constipation or diarrhea due to gastrointestinal dysmotility may also occur. In the Mayo Clinic study, approximately 39% of POTS patients reported nausea [3].
Other Symptoms
Sudomotor dysfunction (excessive sweating or anhidrosis), dependent acrocyanosis (purple discoloration of the lower extremities), blurred vision, tremor, dyspnea, and facial flushing have been reported. The type and severity of symptoms vary widely among patients and are exacerbated by the menstrual cycle, heat, dehydration, and prolonged standing.
Diagnosis
The diagnosis of POTS is established by integrating clinical symptoms, hemodynamic responses upon standing, and exclusion of other conditions [1] [7].
Tilt Table Test
This is the standard diagnostic test. The patient is placed supine on the tilt table and rests for 5–10 minutes before being tilted to a 60–70 degree angle. POTS is diagnosed if heart rate increases by 30 bpm or more (40 bpm or more for ages 12–19) or the absolute heart rate exceeds 120 bpm within 10 minutes of tilting, without a drop in systolic blood pressure of 20 mmHg or more [1]. False positives due to dehydration, medications, or prolonged bed rest must be excluded.
Active Standing Test
This is a simple screening test that can be performed in the outpatient setting. Blood pressure and heart rate are measured at 1, 3, 5, and 10 minutes after the patient actively stands up. The same diagnostic criteria as the tilt table test are applied, although results may differ slightly because the patient uses their own muscles to stand.
Heart Rate Variability (HRV) Analysis
This test evaluates the sympathovagal balance of the autonomic nervous system by analyzing minute variations in heartbeat intervals. In POTS patients, increased sympathetic activity and decreased parasympathetic function at rest are frequently observed [5]. HRV analysis is also used for monitoring treatment efficacy.
Plasma Catecholamine Measurement
Blood is drawn in the upright position to measure plasma norepinephrine levels. An upright norepinephrine level of 600 pg/mL or above suggests hyperadrenergic POTS [2]. Measurements are taken in both the supine and upright positions for comparison.
Autoantibody Testing
This is performed when autoimmune POTS is suspected. Tests include antinuclear antibodies (ANA), anti-SSA/SSB antibodies, and ganglionic acetylcholine receptor (AChR) antibodies [5]. Positive results provide a basis for immunomodulatory therapy.
Additional Tests
Thyroid function tests, 24-hour urinary sodium excretion, plasma volume measurement, quantitative sudomotor axon reflex test (QSART), and skin biopsy (for small fiber neuropathy assessment) may be performed to differentiate subtypes and identify the underlying cause. It is essential to exclude conditions that present with similar symptoms, including pheochromocytoma, inappropriate sinus tachycardia, anxiety disorders, and hyperthyroidism.
Treatment
The treatment of POTS follows a stepwise approach based on non-pharmacological interventions, with medications added when symptom control is inadequate [1] [5].
Non-pharmacological Treatment
Non-pharmacological treatment forms the foundation of care for all POTS patients.
Fluid and salt supplementation is the most fundamental measure. Daily intake of 2–3 liters of water and 6–10 g of salt is recommended [1]. Increasing fluid and salt intake expands plasma volume, alleviating orthostatic symptoms.
Compression garments rated at 30–40 mmHg that extend to the waist are effective [2]. Abdominal compression garments are more effective than lower-extremity-only stockings in reducing splanchnic blood pooling.
Postural management is also beneficial. Elevating the head of the bed by 10–15 degrees during sleep can reduce nocturnal diuresis and alleviate morning symptoms. Patients should avoid abrupt postural changes and activate the lower extremity muscle pump by crossing legs or rising on tiptoes when standing.
Pharmacological Treatment
No single medication controls all symptoms; drug selection is guided by the subtype and predominant symptoms [1].
Low-dose beta-blockers (propranolol 10–20 mg, 2–3 times daily) are effective for heart rate control. In a study by Raj et al. (2009), propranolol 20 mg significantly reduced upright heart rate compared to placebo [2]. High-dose use may worsen fatigue and exercise intolerance and requires caution.
Midodrine (2.5–10 mg, 3 times daily) is an alpha-1 agonist that constricts peripheral blood vessels to improve venous return. It helps maintain blood pressure upon standing and reduces lower extremity blood pooling [1].
Ivabradine (2.5–7.5 mg, twice daily) selectively inhibits the If current in the sinoatrial node to lower heart rate. An increasing body of evidence supports its efficacy in significantly reducing upright heart rate and improving symptoms in POTS patients [5].
Fludrocortisone (0.1–0.2 mg/day) promotes sodium and water reabsorption to expand plasma volume [1]. Potential adverse effects including hypokalemia, headache, and edema should be monitored.
Pyridostigmine (30–60 mg, 3 times daily) is a cholinesterase inhibitor that enhances neurotransmission at autonomic ganglia and is used for milder forms of POTS [1].
When autoimmune POTS is confirmed, intravenous immunoglobulin (IVIG) or immunomodulatory therapy may be attempted [5].
Neuromodulation Therapy
Stellate ganglion block involves injecting a local anesthetic into the sympathetic ganglion to temporarily suppress sympathetic output in cases of marked sympathetic overactivation. Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation technique that aids in restoring the function of autonomic regulatory centers.
Exercise Rehabilitation
Exercise is the non-pharmacological intervention with the strongest evidence base in POTS treatment [4].
Dallas Protocol
The graded exercise program developed by Fu and Levine (2018) was specifically designed for POTS patients [4]. Approximately 71% of POTS patients who completed the 3-month structured exercise program achieved a reduction in heart rate increase to below the diagnostic threshold, effectively no longer meeting POTS diagnostic criteria [4]. The program consists of the following phases.
Phase 1 (months 1–2) is the recumbent exercise phase. Exercises with minimal orthostatic stress, such as recumbent cycling, rowing, and swimming, are performed 3–4 times per week for 25–30 minutes per session, targeting 70–75% of maximum heart rate.
Phase 2 (months 2–3) is the progressive upright exercise phase. Upright exercises such as stationary cycling and walking are gradually added to the recumbent exercises. Exercise frequency is increased to 4–5 times per week, and session duration is extended to 35–45 minutes.
Phase 3 (beyond month 3) is the maintenance phase. Standard aerobic exercises (jogging, regular cycling) are performed 5–6 times per week for 45–60 minutes per session, with resistance training added 1–2 times per week. As cardiovascular fitness improves, the heart rate response to standing normalizes.
This program increases left ventricular volume by approximately 8% and expands plasma volume by approximately 6% [4]. Symptoms may temporarily worsen during the first 1–2 weeks of exercise, but persisting through this period leads to gradual improvement, making it important not to give up.
Exercise Precautions
Upright exercise should only be started after the patient has adapted to recumbent exercise. Exercise in hot environments should be avoided because heat provokes vasodilation; exercising in cool environments is recommended. Adequate fluid and electrolyte intake before and after exercise is essential, and if symptoms acutely worsen, exercise should be stopped and the patient should lie down. Keeping an exercise diary can help with appropriate intensity adjustment.
Lifestyle Guide
Fluid and Salt Intake
Drink 2–3 liters of water daily in small, frequent amounts throughout the day. Drinking 500 mL of water immediately upon waking helps alleviate morning orthostatic symptoms. Salt intake of 6–10 g per day with meals is recommended, but patients with cardiac or renal disease must consult their physician [1]. Electrolyte drinks may be helpful, but products with excessive sugar content should be avoided.
Posture Management
When transitioning from lying to standing, sit on the edge of the bed for 1–2 minutes before slowly standing up. In situations requiring prolonged standing, crossing the legs or rising on tiptoes activates the lower extremity muscle pump. During prolonged sitting, periodically perform ankle pump exercises (dorsiflexion and plantarflexion). Elevating the head of the bed by 10–15 cm using bricks or a riser reduces nocturnal urination and helps maintain morning plasma volume.
Environmental Management
Hot environments cause vasodilation and worsen symptoms. Use lukewarm rather than hot water for showers, and avoid saunas and steam rooms. Keep indoor temperatures cool, and use cooling vests or portable fans when going outdoors. Excessive alcohol consumption causes dehydration and vasodilation and should be limited.
Dietary Management
Large meals can worsen orthostatic symptoms by increasing splanchnic blood flow during digestion. Eating smaller, more frequent meals is preferable. High-carbohydrate meals can provoke postprandial hypotension, so a low-carbohydrate, high-protein diet is recommended [2].
Daily Tips
Keep a symptom diary to identify exacerbating factors (menstrual cycle, weather, sleep, meals, etc.). Wear compression stockings and maintain adequate hydration during air travel and long car rides. Maintaining a regular sleep schedule (waking at the same time daily) helps stabilize the autonomic nervous system. If possible, inform your workplace or school about your condition to create an environment that does not require prolonged standing.